ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
A Label-Free Ultraviolet Photoacoustic Microscopy Enables Nuclear Imaging and Toxicity Assessment in an Intact Brain Organoid.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Fetal alcohol spectrum disorders (FASDs) are caused by prenatal exposure to ethanol (EtOH), leading to developmental brain abnormalities. Cortical organoids derived from human-induced pluripotent stem cells provide physiologically relevant models to study such neurotoxic effects. However, accurate imaging of nuclear morphology, a key indicator of cytotoxicity and developmental impairment, remains difficult. Traditional fluorescence-based techniques rely on staining and sectioning, limiting throughput and potentially altering native structures. Herein, we present an ultraviolet photoacoustic microscopy system that targets endogenous nucleic acids at 266 nm excitation, resulting in a lateral resolution of 278 nm, which is sufficient to resolve individual nuclei in situ. The system integrates precise z-axis scanning for focal-plane alignment, enabling high-resolution depth-resolved imaging of subvolumes within 3D intact live organoids without physical sectioning. Using EtOH-treated cortical organoids as a model of FASD-associated neurotoxicity, we observed significant reductions in nuclear area, diameter, and circularity by 46.1%, 20.8%, and 6.0%, respectively, indicating structural damage consistent with apoptosis and impaired neurodevelopment. This method is the first to demonstrate label-free nuclear imaging in intact live brain organoids, providing a robust and preparation-free platform for probing disease-relevant phenotypes, accelerating drug screening, and enabling early toxicity assessments in neurodevelopmental disorder models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.